Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 15Advanced Solid Tumors 7Solid Tumor 6Solid Tumors 5Advanced Solid Tumor 5Mesothelioma 3Peritoneal Neoplasms 2Advanced Solid Tumours 2Urinary Bladder Neoplasms 1Tracheal Neoplasms 1Thyroid Neoplasms 1Solitary Pulmonary Nodule 1Sarcoma 1Resectable Colon Cancer 1Pulmonary Sclerosing Hemangioma 1Pseudomyxoma Peritonei 1Phyllodes Tumor 1Parathyroid Neoplasms 1Pancoast Syndrome 1Ovarian Neoplasms 1Otorhinolaryngologic Neoplasms 1Osteosarcoma 1Neoplasms 1Myxosarcoma 1Myosarcoma 1Mouth Neoplasms 1Mixed Tumor, Mesodermal 1Mesothelioma, Cystic 1Malignant Solid Tumour 1Malignant Solid Tumor 1

Interventions

pembrolizumab 3Ramucirumab 2Nivolumab 2etirinotecan pegol 1cemiplimab 1Ribavirin 1Paclitaxel 1Injections 1Fluorouracil 1Docetaxel 1Decitabine 1Cisplatin 1Carboplatin 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Fluorouracil × Other solid neoplasm × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡